While several studies indicated that GAB2 was associated with tumor metastasis in breast cancer, colorectal cancer, melanoma, and ovarian cancer [16–19], our study failed to reveal a significant relationship between GAB2 expression and lymph node metastasis in PDAC patients. This evidence concerns the gene GAB2 and ovarian cancer.